Search

M2 PRESSWIRE-November 19, 2024-: Menopause Market Size in the 7MM was ~USD 10,970 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:18112024 The Menopause Market is driven by the rising [...]

M2 PRESSWIRE-August 22, 2024-: Metastatic Bone Pain Market to Register Incremental Growth During the Forecast Period | Progenics, Q.Biomed, Shanghai JMT-Bio, Qilu Pharma (C)1994-2024 M2 COMMUNICATIONS RDATE:21082024 DelveInsight's 'Metastatic Bone [...]

M2 PRESSWIRE-June 10, 2024-: Bone Metastasis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight | XGEVA (denosumab), XOFIGO (radium-223 dichloride), Cabozantinib, 9-ING-41, more (C)1994-2024 M2 [...]

M2 PRESSWIRE-May 10, 2024-: Chronic Wounds Market 2032: Epidemiology Review, Pipeline Breakthroughs, Regulatory Highlights by DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, Abeona Therapeutics, Inc, CereMark Pharma (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-February 27, 2024-: Osteogenesis Imperfecta Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Mereo BioPharma, Amgen Pharmaceuticals (C)1994-2024 M2 COMMUNICATIONS RDATE:27022024 'Osteogenesis Imperfecta Market [...]

M2 PRESSWIRE-December 7, 2023-: Growth Anticipated in Plasma Cell Leukemia Market Over 2023-2032, DelveInsight's Analysis | Spotlight on Key Players - Denovo Biopharma, Orbus Therapeutics, and Genetech (C)1994-2023 M2 COMMUNICATIONS [...]

Dublin: Research and Markets has issued the following news release: The 'Osteoporosis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis' report has [...]

(GlobeNewswire) - The 'Osteoporosis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis' report has been added to ResearchAndMarkets.com's offering. The global osteoporosis [...]

M2 PRESSWIRE-May 24, 2023-: Plasma Cell Leukemia Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - Denovo Biopharma, [...]

SAN FRANCISCO, May 18, 2023 /PRNewswire/ --The global https://www.grandviewresearch.com/industry-analysis/womens-health-market?utm_source=prnewswire&utm_medium=referral&utm_campaign=HC_18-May-23&utm_term=womens_health_market&utm_content=rd size is expected to reach USD 63.02 billion by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to [...]

New York, USA, May 11, 2023 (GLOBE NEWSWIRE) -- Plasma Cell Leukemia Market is Expected to Showcase Significant Growth, Predicts DelveInsight | Key Companies in the Space - AbbVie, Bristol-Myers [...]

M2 PRESSWIRE-March 13, 2023-: Post-Menopausal Osteoporosis Pipeline Assets Segmented By Stage, Product Type, Route of Administration, and Molecule Type (C)1994-2023 M2 COMMUNICATIONS RDATE:10032023 DelveInsight's, 'Postmenopausal Osteoporosis Pipeline Insight 2023' report [...]

M2 PRESSWIRE-November 17, 2022-: Bone Metastasis in Solid Tumors Market to Grow Substantially During the Forecast Period (2022-32) - DelveInsight | Key Companies - Actuate Therapeutics, Exelixis, Bayer, Amgen (C)1994-2022 [...]

M2 PRESSWIRE-November 10, 2022-: Osteogenesis Imperfecta Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Mereo BioPharm, Amgen Pharmaceuticals (C)1994-2022 M2 [...]

New York: Reportlinker.com announces the release of the report 'Women's Health Market Size, Share & Trends Analysis Report By Application, By Age, By Region And Segment Forecasts, 2022 - 2030' [...]

New York, June 10, Jun 10, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END Reportlinker.com announces the release of the report 'Women's Health Market Size, Share & Trends Analysis Report [...]

Dublin, Jan 21, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Global Biosimilars Market - Products, Applications and Regulations' report has been added to ResearchAndMarkets.com's offering. Due to the COVID-19 Pandemic, [...]

DUBLIN: Research and Markets has issued the following press release: The 'Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, [...]

(GlobeNewswire) - The 'Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), By Regions (North America, Europe, Asia [...]

DUBLIN -- The 'Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), By Regions (North America, Europe, Asia [...]

M2 PRESSWIRE-November 20, 2019-: Global Osteoporosis Drugs Market Expected to Grow with a CAGR of 4.3% During the Forecast Period, 2019-2025 (C)1994-2019 M2 COMMUNICATIONS RDATE:20112019 The 'Osteoporosis Drugs Market - [...]

M2 PRESSWIRE-October 21, 2019-: Chordoma Disease Market 2019 Trends, Statistics, Size, Share, Key Companies, Growth, And Regional Outlook To 2023 (C)1994-2019 M2 COMMUNICATIONS RDATE:21102019 The report provides an in-depth analysis [...]

Dublin: Research and Markets has issued the following press release: The 'Osteoporosis: Global Drug Forecast and Market Analysis to 2027' report has been added to ResearchAndMarkets.com's offering. Despite being a [...]

M2 PRESSWIRE-July 5, 2019-: Osteoporosis: Global Drug Forecast & Market Analysis to 2027 (C)1994-2019 M2 COMMUNICATIONS RDATE:05072019 The 'Osteoporosis: Global Drug Forecast and Market Analysis to 2027' report has been [...]

Dublin, March 19, Mar 19, 2019 (GLOBE NEWSWIRE via COMTEX) -- The 'Bone Cancer Treatment Market - Growth, Trends, and Forecast (2019-2024)' report has been added to ResearchAndMarkets.com's offering. The [...]